Purine Analogue 6-Methylmercaptopurine Riboside Inhibits Early And Late Phases Of The Angiogenesis Process

CANCER RESEARCH, no. 10 (1999): 2417-2424

引用83|浏览21
WOS
下载 PDF 全文
引用

摘要

Angiogenesis has been identified as an important target for antineoplastic therapy. The use of purine analogue antimetabolites in combination chemotherapy of solid tumors has been proposed. To assess the possibility that selected purine analogues may affect tumor neovascularization, 6-methylmercaptopurine riboside (6-MMPR), 6-methylmercap...更多

代码

数据

0
您的评分 :

暂无评分

标签
评论
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn